These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6303993)

  • 1. Efficacy testing of WR-2721 in Great Britain everything is black and white at the gray lab.
    Yuhas JM
    Int J Radiat Oncol Biol Phys; 1983 Apr; 9(4):595-8. PubMed ID: 6303993
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental radiotherapy with WR-2721 and misonidazole.
    Rojas A; Stewart FA; Denekamp J
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):527-30. PubMed ID: 6286547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of bone marrow by WR-2721 after fractionated irradiation.
    Coia LR; Brown DQ
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):908-9. PubMed ID: 2550401
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy.
    Yuhas JM; Yurconic M; Kligerman MM; West G; Peterson DF
    Radiat Res; 1977 May; 70(2):433-43. PubMed ID: 193145
    [No Abstract]   [Full Text] [Related]  

  • 5. The time course of radioprotection by WR 2721 in mouse skin.
    Travis EL; De Luca AM; Fowler JF; Padikal TN
    Int J Radiat Oncol Biol Phys; 1982 May; 8(5):843-50. PubMed ID: 6286557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of WR-2721 in radiotherapy and/or chemotherapy.
    Yuhas JM; Spellman JM; Culo F
    Cancer Clin Trials; 1980; 3(3):211-6. PubMed ID: 6254681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the radioprotective drugs MEA, DMSO, and WR-2721 on tumor control and skin tolerance in the rat.
    Moulder JE; Lo PS; Fischer JJ
    Cancer Treat Rep; 1977 Aug; 61(5):825-33. PubMed ID: 196752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of normal tissues by WR2721 during fractionated irradiation.
    Utley JF; Phillips TL; Kane LJ
    Int J Radiat Oncol Biol Phys; 1976; 1(7-8):699-703. PubMed ID: 185172
    [No Abstract]   [Full Text] [Related]  

  • 9. Fractionation studies with WR-2721: normal tissues and tumour.
    Rojas A; Stewart FA; Soranson JA; Smith KA; Denekamp J
    Radiother Oncol; 1986 May; 6(1):51-60. PubMed ID: 3012656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
    Rojas A; Stewart FA; Denekamp J
    Br J Cancer; 1983 Jan; 47(1):65-72. PubMed ID: 6295429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of WR 2721 on the efficacy of radiotherapy and chemotherapy of murine tumors.
    Clement JJ; Johnson RK
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):539-42. PubMed ID: 6286550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitizers and protectors in clinical oncology.
    Phillips TL
    Semin Oncol; 1981 Mar; 8(1):65-82. PubMed ID: 6264627
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioprotective effect of WR-2721 (gammaphos) or cystamine in non-uniform lethal gamma irradiated mice.
    Kuna P
    Radiobiol Radiother (Berl); 1986; 27(6):761-9. PubMed ID: 3033737
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of tumor type, size, and endpoint on tumor radioprotection by WR-2721.
    Milas L; Hunter N; Ito H; Peters LJ
    Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):41-8. PubMed ID: 6321411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A more general role for WR-2721 in cancer therapy.
    Yuhas JM
    Br J Cancer; 1980 May; 41(5):832-4. PubMed ID: 6252918
    [No Abstract]   [Full Text] [Related]  

  • 16. Need for studies on factors that influence radioprotection of solid tumors by WR-2721.
    Milas L
    Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):163-5. PubMed ID: 6321410
    [No Abstract]   [Full Text] [Related]  

  • 17. Radioprotection combined with hypoxic sensitization during radiotherapy of a solid murine tumor.
    Mendiondo OA; Grigsby PW; Beach JL
    Radiology; 1983 Jul; 148(1):291-3. PubMed ID: 6304811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the outlook grey for WR-2721 as a clinical radioprotector?
    Denekamp J; Stewart FA; Rojas A
    Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1247-9. PubMed ID: 6307942
    [No Abstract]   [Full Text] [Related]  

  • 19. WR-2721: a chemotherapy and radiation-protective agent.
    Schein PS
    Cancer Invest; 1990; 8(2):265-6. PubMed ID: 2169331
    [No Abstract]   [Full Text] [Related]  

  • 20. Modification of radiosensitivity of bone marrow lymphocytes by WR-2721.
    Naruka K; Bhartiya HC
    Acta Oncol; 1987; 26(4):317-8. PubMed ID: 2825734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.